NPC-supported companies are pioneering new technologies

The global demand for protein is creating multiple pressures on the agrifood industry. NovoBind, one of NPC’s earliest investee companies, i

Canadian start-up Novobind Livestock Therapeutics has started raising investment to support the development of its nanobody-based biologics.

Canadian innovators are reimagining the agri-food industry.

NovoBind’s novel biotherapeutic solutions have shown positive results in whiteleg shrimp against EMS.

Emerging protein technologies, like precision biologics, have the potential to provide targeted disease prevention against costly pathogens.

NovoBind aims to move nanobodies from preliminary success into industrial studies by Joseph Harvey, editor of IHS Markit Animal Health.

Single domain antibody fragments will take overtake traditional antibodies in the coming years by Joseph Harvey, editor of IHS Markit Animal

“Precision biologics: the key to reducing antibiotic use in livestock? Combining the science of nanoencapsulation”